Skip to main content
. 2021 Oct 14;12:733225. doi: 10.3389/fimmu.2021.733225

Figure 3.

Figure 3

Validation of alteration in protein and metabolite levels in late pregnancy. (A) Placental levels of L-palmitoylcarnitine and glycocholic acid in ICP and control groups (P=0.006, P=0.000, respectively); (B) serum levels of L-palmitoylcarnitine in ICP and control groups (P=0.010); (C) serum levels of glycocholic acid in ICP and control groups (P=0.000); (D) serum levels of ACOX1 in ICP and control groups (P=0.000). (E) serum levels of L-palmitoylcarnitine in mild and severe ICP groups (P=0.000); (F) serum levels of glycocholic acid in mild and severe ICP groups (P=0.000); (G) serum levels of ACOX1 in mild and severe ICP groups (P=0.000). (**P < 0.01; *P < 0.05).